Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis
暂无分享,去创建一个
M. Jeong | Young Jo Kim | M. Cho | C. Kim | S. Chae | T. Hong | I. Seong | J. Chae | K. Seung | Seung‐Jung Park | Y. Jang | Dong-gu Shin | J. Bae | J. Sohn | G. Hong | W. Chung | S. Rha | S. Hur | D. Choi | I. Chae | J. Yoon | Jong Seon Park | J. Rhew | H. Jo | J. Yoon | C. W. Sohn | Sang Hee Lee | D. Shin
[1] Fred S Apple,et al. Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.
[2] Min Chul Kim,et al. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization. , 2011, International journal of cardiology.
[3] J. Cho,et al. Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction , 2010, Journal of Korean medical science.
[4] Jae-Seok Hong,et al. Long-Term Trend in the Incidence of Acute Myocardial Infarction in Korea: 1997-2007 , 2009, Korean circulation journal.
[5] G. Sangiorgi,et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up , 2009, Heart.
[6] Sunil V. Rao,et al. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). , 2009, The American journal of cardiology.
[7] Ju Han Kim,et al. Differences in Clinical Outcomes Between Patients With ST-Elevation Versus Non-ST-Elevation Acute Myocardial Infarction in Korea , 2009, Korean circulation journal.
[8] M. Jeong,et al. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. , 2009, International journal of cardiology.
[9] F. Veglia,et al. Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.
[10] J. Cho,et al. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. , 2008, International journal of cardiology.
[11] M. Jeong,et al. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[12] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[13] E. Topol,et al. Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. , 2006, The American journal of cardiology.
[14] Lippincott Williams Wilkins,et al. ACC/AHA/SCAI Practice Guidelines, February 21, 2006 , 2006 .
[15] J. Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Circulation.
[16] G. Parodi,et al. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience , 2005, Heart.
[17] P. Serruys,et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. , 2004, American heart journal.
[18] C. W. Barth,et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. , 2004, American heart journal.
[19] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[20] C. Grines,et al. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. , 2001, The American journal of cardiology.
[21] I. Schmoelzer,et al. Multiple complex coronary plaques in patients with acute myocardial infarction. , 2001, The New England journal of medicine.
[22] M. Leon,et al. Procedural results and late clinical outcomes following multivessel coronary stenting. , 1998, Journal of the American College of Cardiology.
[23] J. Moses,et al. Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting. , 1997, Circulation.
[24] K. Lee,et al. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1991, American heart journal.
[25] S. Ellis,et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. , 1988, Circulation.
[26] Deepak L. Bhatt,et al. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. , 2008, American heart journal.
[27] G. Pasterkamp,et al. Multiple complex coronary plaques in patients with acute myocardial infarction. , 2001, The New England journal of medicine.